Fundz

Real-time funding, M&A, exec moves & hiring — the signals that move deals

More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.

The funding market, moving in real timeBook a DemoChoose your plan
Loading live signals…

Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.

Back to SEC Filings
Executive ChangeItem 5.02 · 8-KMEDIUM RiskNeutral

Advanced Biomed Inc.

advanbiomed.com
Filed: Mar 25, 2026TainanCIK: 0001941029Health Care
Watch CompanyView on SEC.gov

AI Executive Summary

AI-powered analysis of 8-K filing content

Advanced Biomed Inc. experienced a leadership transition on March 25, 2026, with the resignation of Steven I-Fang Cheng as Board Director and Chief Technology Officer, while Mingze Yin was appointed as Director while retaining his CFO role. This change signals potential strategic repositioning but maintains governance continuity.

Key Takeaways

Steven I-Fang Cheng departed as both Board Director and Chief Technology Officer effective immediately on March 25, 2026

Mingze Yin, the current Chief Financial Officer, was appointed to the Board of Directors on the same date

2 more takeaways

Related Filings (1)

1 more filing from Advanced Biomed Inc. in the last 90 days

Filing Overview

Form Type8-K
Filing DateMar 25, 2026
Item5.02
CategoryExecutive Change
CIK0001941029
Accession #0001941029
Risk LevelMEDIUM
SentimentNeutral
Signalinformational
Topics
executive departureleadership transitionboard change

What This Means

A senior executive (CEO, CFO, etc.) has joined, departed, or changed roles. Leadership changes can significantly impact strategy.
View Full Filing on SEC.govBrowse More Filings